DexCom
DXCM
920 hedge funds and large institutions have $41.8B invested in DexCom in 2022 Q4 according to their latest regulatory filings, with 180 funds opening new positions, 327 increasing their positions, 317 reducing their positions, and 39 closing their positions.
362% more first-time investments, than exits
New positions opened: 180 | Existing positions closed: 39
136% more funds holding in top 10
Funds holding in top 10: 11 → 26 (+15)
40% more capital invested
Capital invested by funds: $29.9B → $41.8B (+$11.9B)
16% more funds holding
Funds holding: 794 → 920 (+126)
3% more repeat investments, than reductions
Existing positions increased: 327 | Existing positions reduced: 317
0.92% more ownership
Funds ownership: 94.76% → 95.68% (+0.92%)
1% less call options, than puts
Call options by funds: $636M | Put options by funds: $641M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$292M |
| 2 |
Jennison Associates
New York
|
+$246M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$174M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$147M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$120M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$780M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$518M |
| 3 |
Sands Capital Management
Arlington,
Virginia
|
-$129M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$117M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$88.3M |
DXCM Hedge Fund Activity: Q4 2022 in Review
920 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q4 2022, worth a combined $41.8B — up 40% from $29.9B a quarter earlier.
Buyers outnumbered sellers: 180 funds opened new DXCM positions and 39 closed out — a net gain of 141 holders — while 327 added to existing stakes and 317 trimmed.
The largest buyer was Millennium Management, adding an estimated $292M. The largest seller was Janus Henderson Group, cutting an estimated $780M.
- 920 institutional investors held DexCom (DXCM) as of Q4 2022, up from 794 in Q3 2022.
- Funds reported $41.8B of DexCom stock for Q4 2022, up 40% quarter-over-quarter.
- 180 funds opened new DexCom positions in Q4 2022 and 39 closed out, a net change of +141 holders.
- The largest DexCom buyer in Q4 2022 was Millennium Management, an estimated $292M added.
- The largest DexCom seller in Q4 2022 was Janus Henderson Group, an estimated $780M sold.
Based on aggregated 13F filings for Q4 2022.